Cardiac product developers see hearty revenues
This article was originally published in Clinica
Sales growth in Angeion's line of cardiorespiratory diagnostic products and its New Leaf Health and Fitness franchise has led to an overall 10% increase in second-quarter revenues for 2004. During this period, the St Paul, Minnesota company began shipment of its new CPX Ultima gas exchange metabolic cart system. New losses recorded for both second-quarter and first-half periods were due to charges relating to the discontinuation of its implantable cardioverter defibrillator (ICD) product line at the end of 1999.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.